174 related articles for article (PubMed ID: 19270645)
1. Immunohistochemical comparison of MUC1, CA125, and Her2Neu in invasive micropapillary carcinoma of the urinary tract and typical invasive urothelial carcinoma with retraction artifact.
Sangoi AR; Higgins JP; Rouse RV; Schneider AG; McKenney JK
Mod Pathol; 2009 May; 22(5):660-7. PubMed ID: 19270645
[TBL] [Abstract][Full Text] [Related]
2. Invasive micropapillary urothelial carcinoma of the bladder.
Lopez-Beltran A; Montironi R; Blanca A; Cheng L
Hum Pathol; 2010 Aug; 41(8):1159-64. PubMed ID: 20381120
[TBL] [Abstract][Full Text] [Related]
3. Micropapillary variant of urothelial carcinoma of the urinary bladder; a clinicopathological and immunohistochemical study.
Samaratunga H; Khoo K
Histopathology; 2004 Jul; 45(1):55-64. PubMed ID: 15228444
[TBL] [Abstract][Full Text] [Related]
4. Cell Polarity Reversal Distinguishes True Micropapillary Growth From Retraction Artifact in Invasive Urothelial Carcinoma.
Hui Y; Lombardo KA; Quddus MR; Matoso A
Appl Immunohistochem Mol Morphol; 2018 Jan; 26(1):e1-e6. PubMed ID: 28800010
[TBL] [Abstract][Full Text] [Related]
5. Human Epidermal Growth Factor Receptor 2 Overexpression in Micropapillary and Other Variants of Urothelial Carcinoma.
Behzatoğlu K; Yörükoğlu K; Demir H; Bal N
Eur Urol Focus; 2018 Apr; 4(3):399-404. PubMed ID: 28753766
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of invasive micropapillary carcinoma: role of MUC1 glycoprotein.
Nassar H; Pansare V; Zhang H; Che M; Sakr W; Ali-Fehmi R; Grignon D; Sarkar F; Cheng J; Adsay V
Mod Pathol; 2004 Sep; 17(9):1045-50. PubMed ID: 15154007
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of prominent retraction clefts in invasive urothelial carcinoma.
Shah TS; Kaag M; Raman JD; Chan W; Tran T; Kunchala S; Shuman L; DeGraff DJ; Chen G; Warrick JI
Hum Pathol; 2017 Mar; 61():90-96. PubMed ID: 27818288
[TBL] [Abstract][Full Text] [Related]
8. The expression of Wilms' tumour-1 and Ca125 in invasive micropapillary carcinoma of the breast.
Lee AH; Paish EC; Marchio C; Sapino A; Schmitt FC; Ellis IO; Reis-Filho JS
Histopathology; 2007 Dec; 51(6):824-8. PubMed ID: 18042071
[TBL] [Abstract][Full Text] [Related]
9. Invasive micropapillary carcinoma of the urinary bladder: an immunohistochemical study of neoplastic and stromal cells.
Kuroda N; Tamura M; Ohara M; Hirouchi T; Mizuno K; Miyazaki E
Int J Urol; 2006 Jul; 13(7):1015-8. PubMed ID: 16882079
[TBL] [Abstract][Full Text] [Related]
10. E-cadherin expression in plasmacytoid, signet ring cell and micropapillary variants of urothelial carcinoma: comparison with usual-type high-grade urothelial carcinoma.
Lim MG; Adsay NV; Grignon DJ; Osunkoya AO
Mod Pathol; 2011 Feb; 24(2):241-7. PubMed ID: 20818341
[TBL] [Abstract][Full Text] [Related]
11. Non-invasive papillary urothelial carcinoma with 'micropapillary' architecture: clinicopathological study of 18 patients emphasising clinical outcomes.
Sangoi AR; Cox RM; Higgins JP; Quick CM; McKenney JK
Histopathology; 2020 Nov; 77(5):728-733. PubMed ID: 32443178
[TBL] [Abstract][Full Text] [Related]
12. Stromal Lymphoid Response Status in Micropapillary Urothelial Carcinomas Diagnosed in Bladder Transurethral Resections and its Comparison with Conventional Urothelial Carcinomas.
HacihasanoĞlu E; YÜcetaŞ U; OkÇu O; BehzatoĞlu K
Turk Patoloji Derg; 2021; 37(1):26-31. PubMed ID: 32692402
[TBL] [Abstract][Full Text] [Related]
13. Invasive micropapillary carcinoma of the breast metastatic to the urinary bladder and endometrium: diagnostic pitfalls and review of the literature of tumors with micropapillary features.
Ramalingam P; Middleton LP; Tamboli P; Troncoso P; Silva EG; Ayala AG
Ann Diagn Pathol; 2003 Apr; 7(2):112-9. PubMed ID: 12715337
[TBL] [Abstract][Full Text] [Related]
14. Outcome of patients with micropapillary urothelial carcinoma following radical cystectomy: ERBB2 (HER2) amplification identifies patients with poor outcome.
Schneider SA; Sukov WR; Frank I; Boorjian SA; Costello BA; Tarrell RF; Thapa P; Houston Thompson R; Tollefson MK; Jeffrey Karnes R; Cheville JC
Mod Pathol; 2014 May; 27(5):758-64. PubMed ID: 24186136
[TBL] [Abstract][Full Text] [Related]
15. Micropapillary urothelial carcinoma: evaluation of HER2 status and immunohistochemical characterization of the molecular subtype.
Zinnall U; Weyerer V; Compérat E; Camparo P; Gaisa NT; Knuechel-Clarke R; Perren A; Lugli A; Toma M; Baretton G; Kristiansen G; Wirtz RM; Cheng L; Wullich B; Stoehr R; Hartmann A; Bertz S
Hum Pathol; 2018 Oct; 80():55-64. PubMed ID: 29885409
[TBL] [Abstract][Full Text] [Related]
16. FOXA1 and CK14 as markers of luminal and basal subtypes in histologic variants of bladder cancer and their associated conventional urothelial carcinoma.
Warrick JI; Kaag M; Raman JD; Chan W; Tran T; Kunchala S; Shuman L; DeGraff D; Chen G
Virchows Arch; 2017 Sep; 471(3):337-345. PubMed ID: 28721490
[TBL] [Abstract][Full Text] [Related]
17. Reversed polarity of the glandular epithelial cells in micropapillary carcinoma of the large intestine and the EMA/MUC1 immunostain.
Cserni G
Pathology; 2014 Oct; 46(6):527-32. PubMed ID: 25158820
[TBL] [Abstract][Full Text] [Related]
18. Utility of GATA-3 and Cytokeratin 5/6 Immunostains in Separating Condyloma Acuminatum Arising in the Urinary Tract From Non-Invasive Papillary Urothelial Carcinoma.
Montoya-Cerrillo D; Briski LM; Jorda M; Kryvenko ON
Int J Surg Pathol; 2022 May; 30(3):260-264. PubMed ID: 34665053
[No Abstract] [Full Text] [Related]
19. High Grade T1 Papillary Urothelial Bladder Cancer Shows Prominent Peritumoral Retraction Clefting.
Džombeta T; Krušlin B
Pathol Oncol Res; 2018 Jul; 24(3):567-574. PubMed ID: 28752222
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical, molecular, and clinicopathological analyses of urothelial carcinoma, micropapillary variant.
Ishii S; Ohbu M; Toomine Y; Nishimura Y; Hattori M; Yokoyama M; Toyonaga M; Kakinuma H; Matsumoto K
Pathol Int; 2011 Dec; 61(12):723-30. PubMed ID: 22126379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]